New York, NY -- (SBWIRE) -- 01/02/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: POZEN Inc (NASDAQ:POZN), ChemoCentryx Inc (NASDAQ:CCXI), Hersha Hospitality Trust (NYSE:HT), Rigel Pharmaceuticals, Inc (NASDAQ:RIGL),
POZEN Inc (NASDAQ:POZN) showed a volume of 1.13 million shares by the end of last trade whereas the average volume of the stock remained 596,988.00 shares. The stock opened the session at $7.72 but then moved to $8.04. At that price, the stock showed a positive performance of 1.77%. POZEN Inc. (POZEN), is a pharmaceutical company focused on transforming medicine. The Company had developed Treximet in collaboration with GlaxoSmithKline (GSK). Treximet is the brand name for the product combining sumatriptan 85 milligram, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet designed for the acute treatment of migraine.
Will POZN Continue To Move Higher? Find Out Here
ChemoCentryx Inc (NASDAQ:CCXI) opened the session at $5.52 and closed the session at $5.79. The stock showed a positive performance of 5.66% in previous trading session. ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The Company targets the chemokine system, a network of molecules, including chemokine ligands and their associated receptors, as well as related chemo-attractant receptors, all of which are known to drive inflammation. As of December 31, 2011,
For How Long CCXI will fight for Profitability? Read This Trend Analysis report
Hersha Hospitality Trust (NYSE:HT) opened the session at $5.58 and closed the session at $5.57. The stock showed a negative performance of -0.36% in previous trading session. The beta of the stock remained 2.22. Hersha Hospitality Trust is a self-advised Maryland real estate investment trust. The Company invests primarily in institutional grade hotels in urban and central business districts, primary suburban office markets and stable destination and secondary markets in the Northeastern United States, Florida and select markets on the West Coast. The Company owns a general partnership interest in Hersha Hospitality Limited Partnership (HHLP or the Partnership),
Why Should Investors Buy HT After the Recent Fall? Just Go Here and Find Out
Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) the stock advanced 5.56% and finished the session at $2.85. Traded with volume of 1.11 million shares in the prior session and the average volume of the stock remained 1.17 million shares. The beta of the stock remained 1.23. Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. As of December 31, 2011,
Will RIGL Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)